Designing Safer Medicines III

Designing Safer Medicines III

Synopsis

There is a clear need in drug development to reduce attrition from clinical studies especially due to toxicology. It was estimated that a 5-10% improvement in the attrition rate could double the output of marketed drugs. This meeting aims to provide practical insights into some of the recent

preclinical approaches and strategies which have been developed to help the chemist design safer medicines.

Attendees

This meeting is targeted at all those who are involved in the lead identification and lead optimisation processes in Drug Discovery and interested in furthering their knowledge of current and emerging approaches to designing safer Drug Candidates

▼ Show More

15 Belgrave square, SW1X 8PS
London
15 October , Monday 09:00

More Events Nearby

 08 March , Friday
 The Gentleman's Jolly, London
 25 February , Monday
 The Society of Chiropodists and Podiatrists, London
 26 February , Tuesday
 Royal Festival Hall, London